Establishment and molecular cytogenetic characterization of a cell culture model of head and neck squamous cell carcinoma (HNSCC)

Genes

Volumn 1, Issue 3, 2010, Pages 388-412

  Bauer, Verena L ^a   Hieber, Ludwig ^a   Schaeffner, Quirin ^a   Weber, Johannes ^a   Braselmann, Herbert ^a   Huber, Reinhard ^a   Walch, Axel ^a   Zitzelsberger, Horst ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

CAL 33; Cell lines; Cytogenetics; HNSCC

Indexed keywords

ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENE REARRANGEMENT; GENETIC ENGINEERING; GENETIC STABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; KARYOTYPING; METAPHASE; MOLECULAR MODEL; PHENOTYPE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; STRUCTURE ANALYSIS;

EID: 79952078527     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes1030388     Document Type: Article

References (87)

1. Freier, K.; Hofele, C.; Knoepfle, K.; Gross, M.; Devens, F.; Dyckhoff, G.; Plinkert, P.; Lichter, P.; Herold-Mende, C. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes. J. Oral Pathol. Med. 2010, 39, 382-389.
2. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer Statistics, 2010. CA Cancer J. Clin. 2010, 60, 277-300.
3. Burian, M.; Selzer, E.; Kornek, G.V. Fortschritte in der Behandlung von HNO-Tumoren. Onkologie 2002, 25, 26-30.
4. Boehm, A.; Wichmann, G.; Mozet, C.; Dietz, A. Current therapy options in recurrent head and neck cancer. HNO 2010, 58, 762-769.
5. American Cancer Society Cancer Facts & Figures 2010. Available online: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010 (accessed on 20 July 2010).
6. Lehnerdt, G.; Hoffmann, T.K.; Mattheis, S.; Brandau, S.; Zeidler, R.; Lang, S. Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma. HNO 2010, 58, 713-723.
7. Chang, S.S.; Califano, J. Current status of biomarkers in head and neck cancer. J. Surg. Oncol. 2008, 97, 640-643.
8. Wreesmann, V.B.; Shi, W.; Thaler, H.T.; Poluri, A.; Kraus, D.H.; Pfister, D.; Shaha, A.R.; Shah, J.P.; Rao, P.H.; Singh, B. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J. Clin. Oncol. 2004, 22, 3965-3972.
9. Choi, P.; Chen, C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005, 104, 1113-1128.
10. Unger, K.; Malisch, E.; Thomas, G.; Braselmann, H.; Walch, A.; Jackl, G.; Lewis, P.; Lengfelder, E.; Bogdanova, T.; Wienberg, J.; Zitzelsberger, H. Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 2008, 27, 4592-4602.
11. Bauer, V.L.; Braselmann, H.; Henke, M.; Mattern, D.; Walch, A.; Unger, K.; Baudis, M.; Lassmann, S.; Huber, R.; Wienberg, J.; Werner, M.; Zitzelsberger, H.F. Chromosomal changes characterize head and neck cancer with poor prognosis. J. Mol. Med. 2008, 86, 1353-1365.
12. Lin, C.J.; Grandis, J.R.; Carey, T.E.; Gollin, S.M.; Whiteside, T.L.; Koch, W.M.; Ferris, R.L.; Lai, S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007, 29, 163-188.
13. Gioanni, J.; Fischel, J.L.; Lambert, J.C.; Demard, F.; Mazeau, C.; Zanghellini, E.; Ettore, F.; Formento, P.; Chauvel, P.; Lalanne, C.M. et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur. J. Cancer Clin. Oncol. 1988, 24, 1445-1455.
14. Todorovic, V.; Desai, B.V.; Eigenheer, R.A.; Yin, T.; Amargo, E.V.; Mrksich, M.; Green, K.J.; Patterson, M.J. Detection of differentially expressed basal cell proteins by mass spectrometry. Mol. Cell Proteomics 2010, 9, 351-361.
15. Magne, N.; Fischel, J.L.; Dubreuil, A.; Formento, P.; Ciccolini, J.; Formento, J.L.; Tiffon, C.; Renee, N.; Marchetti, S.; Etienne, M.C.; Milano, G. ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine. Clin. Cancer Res. 2003, 9, 4735-4742.
16. Bozec, A.; Sudaka, A.; Toussan, N.; Fischel, J.L.; Etienne-Grimaldi, M.C.; Milano, G. Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model. Ann. Oncol. 2009, 20, 1703-1707.
17. Bozec, A.; Sudaka, A.; Fischel, J.L.; Brunstein, M.C.; Etienne-Grimaldi, M.C.; Milano, G. Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model. Br. J. Cancer 2008, 99, 93-99.
18. Bozec, A.; Lassalle, S.; Gugenheim, J.; Fischel, J.L.; Formento, P.; Hofman, P.; Milano, G. Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126. Br. J. Cancer 2006, 95, 722-728.
19. Bozec, A.; Formento, P.; Lassalle, S.; Lippens, C.; Hofman, P.; Milano, G. Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts. Br. J. Cancer 2007, 97, 65-72.
20. Schrock, E.; du Manoir, S.; Veldman, T.; Schoell, B.; Wienberg, J.; Ferguson-Smith, M.A.; Ning, Y.; Ledbetter, D.H.; Bar-Am, I.; Soenksen, D.; Garini, Y.; Ried, T. Multicolor spectral karyotyping of human chromosomes. Science 1996, 273, 494-497.
21. Miyai, T.; Maruyama, Y.; Osakabe, Y.; Nejima, R.; Miyata, K.; Amano, S. Karyotype changes in cultured human corneal endothelial cells. Mol. Vis. 2008, 14, 942-950.
22. Mamaeva, S.E. Karyotypic evolution of cells in culture: a new concept. Int. Rev. Cytol. 1998, 178, 1-40.
23. Kerler, R.; Rabes, H.M. Karyotype evolution of the clonal rat liver cell line CL 52 during progression in vitro and in vivo. Cancer Genet. Cytogenet. 1996, 87, 140-147.
24. Fitzgerald, P.H.; Morris, C.M.; Rosman, I.; Archer, S.A.; Hollings, P.E. Karyotypic evolution in a B-cell lymphoma. Cancer Genet. Cytogenet. 1987, 24, 271-279.
25. Bahia, H.; Ashman, J.N.; Cawkwell, L.; Lind, M.; Monson, J.R.; Drew, P.J.; Greenman, J. Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int. J. Oncol. 2002, 20, 489-494.
26. Watson, M.B.; Greenman, J.; Drew, P.J.; Lind, M.J.; Cawkwell, L. Variation between independently cultured strains of the MDA-MB-231 breast cancer cell line identified by multicolour fluorescence in situ hybridisation. Cancer Ther. 2004, 2, 167-172.
27. Naim, V.; Rosselli, F. The FANC pathway and mitosis: A replication legacy. Cell Cycle 2009, 8, 2907-2911.
28. D'Andrea, A.D.; Grompe, M. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 2003, 3, 23-34.
29. Wreesmann, V.B.; Estilo, C.; Eisele, D.W.; Singh, B.; Wang, S.J. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J. Otorhinolaryngol Relat. Spec. 2007, 69, 218-225.
30. Squire, J.A.; Bayani, J.; Luk, C.; Unwin, L.; Tokunaga, J.; MacMillan, C.; Irish, J.; Brown, D.; Gullane, P.; Kamel-Reid, S. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 2002, 24, 874-887.
31. Singh, B.; Gogineni, S.K.; Sacks, P.G.; Shaha, A.R.; Shah, J.P.; Stoffel, A.; Rao, P.H. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 2001, 61, 4506-4513.
32. J. Genomic screening of head and neck cancer and its implications for therapy planning. Eur. Arch. Otorhinolaryngol 2006, 263, 297-304.
33. Kallioniemi, A.; Kallioniemi, O.P.; Sudar, D.; Rutovitz, D.; Gray, J.W.; Waldman, F.; Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258, 818-821.
34. Pinkel, D.; Segraves, R.; Sudar, D.; Clark, S.; Poole, I.; Kowbel, D.; Collins, C.; Kuo, W.L.; Chen, C.; Zhai, Y.; Dairkee, S.H.; Ljung, B.M.; Gray, J.W.; Albertson, D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 1998, 20, 207-211.
35. Fiegler, H.; Carter, N.P. Genomic array technology. Methods Cell Biol. 2004, 75, 769-785.
36. Baudis, M.; Cleary, M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001, 17, 1228-1229.
37. Patmore, H.S.; Cawkwell, L.; Stafford, N.D.; Greenman, J. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review. Ann. Surg. Oncol. 2005, 12, 831-842.
38. Zitzelsberger, H.; Hieber, L.; Richter, H.; Unger, K.; Briscoe, C.V.; Peddie, C.; Riches, A. Gene amplification of atypical PKC-binding PARD3 in radiation-transformed neoplastic retinal pigment epithelial cell lines. Gene. Chromosome. Canc. 2004, 40, 55-59.
39. Zitzelsberger, H.; Bauer, V.; Thomas, G.; Unger, K. Molecular rearrangements in papillary thyroid carcinomas. Clin. Chim. Acta 2010, 411, 301-308.
40. Wiech, T.; Nikolopoulos, E.; Weis, R.; Langer, R.; Bartholome, K.; Timmer, J.; Walch, A.K.; Hofler, H.; Werner, M. Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. Lab. Invest. 2009, 89, 385-397.
41. Albrecht, B.; Hausmann, M.; Zitzelsberger, H.; Stein, H.; Siewert, J.R.; Hopt, U.; Langer, R.; Hofler, H.; Werner, M.; Walch, A. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J. Pathol. 2004, 203, 780-788.
42. Singh, B.; Gogineni, S.; Goberdhan, A.; Sacks, P.; Shaha, A.; Shah, J.; Rao, P. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Laryngoscope 2001, 111, 1545-1550.
43. Jin, Y.; Jin, C.; Wennerberg, J.; Hoglund, M.; Mertens, F. Cytogenetic and fluorescence in situ hybridization characterization of chromosome 8 rearrangements in head and neck squamous cell carcinomas. Cancer Genet. Cytogenet. 2001, 130, 111-117.
44. Bockmuhl, U.; Petersen, I. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch. 2002, 441, 541-550.
45. Akervall, J.; Guo, X.; Qian, C.N.; Schoumans, J.; Leeser, B.; Kort, E.; Cole, A.; Resau, J.; Bradford, C.; Carey, T.; Wennerberg, J.; Anderson, H.; Tennvall, J.; Teh, B.T. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin. Cancer Res. 2004, 10, 8204-8213.
46. Bockmuhl, U.; Schwendel, A.; Dietel, M.; Petersen, I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res. 1996, 56, 5325-5329.
47. Huang, Q.; Yu, G.P.; McCormick, S.A.; Mo, J.; Datta, B.; Mahimkar, M.; Lazarus, P.; Schaffer, A.A.; Desper, R.; Schantz, S.P. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Gene. Chromosome. Canc. 2002, 34, 224-233.
48. Liebertz, D.J.; Lechner, M.G.; Masood, R.; Sinha, U.K.; Han, J.; Puri, R.K.; Correa, A.J.; Epstein, A.L. Establishment and Characterization of a Novel Head and Neck Squamous Cell Carcinoma Cell Line USC-HN1. Head Neck Oncol. 2010, 2, 5.
49. Yamaguchi, K.; Okami, K.; Hibi, K.; Wehage, S.L.; Jen, J.; Sidransky, D. Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. Cancer Lett. 1999, 139, 183-187.
50. Reiter, R.; Gais, P.; Steuer-Vogt, M.K.; Boulesteix, A.L.; Deutschle, T.; Hampel, R.; Wagenpfeil, S.; Rauser, S.; Walch, A.; Bink, K.; Jutting, U.; Neff, F.; Arnold, W.; Hofler, H.; Pickhard, A. Centrosome abnormalities in head and neck squamous cell carcinoma (HNSCC). Acta Otolaryngol. 2009, 129, 205-213.
51. Bockmuhl, U.; Petersen, S.; Schmidt, S.; Wolf, G.; Jahnke, V.; Dietel, M.; Petersen, I. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res. 1997, 57, 5213-5216.
52. Califano, J.; van der Riet, P.; Westra, W.; Nawroz, H.; Clayman, G.; Piantadosi, S.; Corio, R.; Lee, D.; Greenberg, B.; Koch, W.; Sidransky, D. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res. 1996, 56, 2488-2492.
53. Speicher, M.R.; Carter, N.P. The new cytogenetics: Blurring the boundaries with molecular biology. Nat. Rev. Genet. 2005, 6, 782-792.
54. Worsham, M.J.; Pals, G.; Schouten, J.P.; Van Spaendonk, R.M.; Concus, A.; Carey, T.E.; Benninger, M.S. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2003, 129, 702-708.
55. Kang, Y.H.; Park, J.E.; Yu, L.R.; Soung, N.K.; Yun, S.M.; Bang, J.K.; Seong, Y.S.; Yu, H.; Garfield, S.; Veenstra, T.D.; Lee, K.S. Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol. Cell. 2006, 24, 409-422.
56. Foltz, D.R.; Jansen, L.E.; Black, B.E.; Bailey, A.O.; Yates, J.R., 3rd; Cleveland, D.W. The human CENP-A centromeric nucleosome-associated complex. Nat. Cell Biol. 2006, 8, 458-469.
57. Lin, L.; Wu, Y.; Li, C.; Zhao, S. Cloning, tissue expression pattern, and chromosome location of a novel human gene BRI3BP. Biochem. Genet. 2001, 39, 369-377.
58. Yamazaki, T.; Sasaki, N.; Nishi, M.; Yamazaki, D.; Ikeda, A.; Okuno, Y.; Komazaki, S.; Takeshima, H. Augmentation of drug-induced cell death by ER protein BRI3BP. Biochem. Biophys. Res. Commun. 2007, 362, 971-975.
59. Lacroix, M. Persistent use of "false" cell lines. Int. J. Cancer 2008, 122, 1-4.
60. Masters, J.R. HeLa cells 50 years on: The good, the bad and the ugly. Nat. Rev. Cancer 2002, 2, 315-319.
61. Schweppe, R.E.; Klopper, J.P.; Korch, C.; Pugazhenthi, U.; Benezra, M.; Knauf, J.A.; Fagin, J.A.; Marlow, L.A.; Copland, J.A.; Smallridge, R.C.; Haugen, B.R. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J. Clin. Endocrinol. Metab. 2008, 93, 4331-4341.
62. Vaidya, M.M.; Borges, A.M.; Pradhan, S.A.; Bhisey, A.N. Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa. Eur. J. Cancer B Oral Oncol. 1996, 32B, 333-336.
63. Walch, A. Helmholtz Zentrum München, Institute of Pathology, Neuherberg, Germany. Personal communication, 2010.
64. Sacks, P.G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev. 1996, 15, 27-51.
65. Neve, R.M.; Chin, K.; Fridlyand, J.; Yeh, J.; Baehner, F.L.; Fevr, T.; Clark, L.; Bayani, N.; Coppe, J.P.; Tong, F.; Speed, T.; Spellman, P.T.; DeVries, S.; Lapuk, A.; Wang, N.J.; Kuo, W.L.; Stilwell, J.L.; Pinkel, D.; Albertson, D.G.; Waldman, F.M.; McCormick, F.; Dickson, R.B.; Johnson, M.D.; Lippman, M.; Ethier, S.; Gazdar, A.; Gray, J.W. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10, 515-527.
66. Sobin, L.H.; Wittekind, C.; International Union against Cancer. Head and neck tumours. In TNM: Classification of Malignant Tumours, 6th ed.; Wiley-Liss: New York, NY, USA, 2002; pp. 19-56.
67. Ragin, C.C.; Modugno, F.; Gollin, S.M. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J. Dent. Res. 2007, 86, 104-114.
68. Pai, S.I.; Westra, W.H. Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu. Rev. Pathol. 2009, 4, 49-70.
69. Wang, X.; Schneider, A. HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia. Carcinogenesis 2010, 31, 1202-1210.
70. Furuse, S.; Adachi, M.; Ijichi, K.; Ohta, S.; Torigoe, S.; Nakazawa, M.; Miura, S.; Mitsudo, K.; Tohnai, I. Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells. Oncol. Rep. 2010, 23, 1339-1343.
71. Cai, C.; Bottcher, M.C.; Werner, J.A.; Mandic, R. Differential expression of VEGF121, VEGF165 and VEGF189 in angiomas and squamous cell carcinoma cell lines of the head and neck. Anticancer Res. 2010, 30, 805-810.
72. Pekkola-Heino, K.; Jaakkola, M.; Kulmala, J.; Grenman, R. Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma. J. Cancer Res. Clin. Oncol. 1995, 121, 452-456.
73. Gerster, K.; Shi, W.; Ng, B.; Yue, S.; Ito, E.; Waldron, J.; Gilbert, R.; Liu, F.F. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77, 253-260.
74. E.J. Radiobiology for the Radiologist, 5th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2000; p. 588S.
75. Amundson, S.A.; Do, K.T.; Vinikoor, L.C.; Lee, R.A.; Koch-Paiz, C.A.; Ahn, J.; Reimers, M.; Chen, Y.; Scudiero, D.A.; Weinstein, J.N.; Trent, J.M.; Bittner, M.L.; Meltzer, P.S.; Fornace, A.J., Jr. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res. 2008, 68, 415-424.
76. Bauchinger, M.; Schmid, E.; Braselmann, H. Time-course of translocation and dicentric frequencies in a radiation accident case. Int. J. Radiat. Biol. 2001, 77, 553-557.
77. Kutlaca, R.; Alder, S.J.; Seshadri, R.S.; Morley, A.A. Radiation sensitivity of human lymphocytes. Mutat. Res. 1982, 94, 125-131.
78. Seshadri, R.; Matthews, C.; Morley, A.A. Radiation sensitivity of human malignant lymphocytes. Acta Radiol. Oncol. 1985, 24, 411-414.
79. Schmid, E.; Roos, H.; Sauter, W.; Rickinger, A.; Jaehnert, I.; Eckardt-Schupp, F. Chromosome analysis of the differential radiosensitivity of an Epstein-Barr virus (EBV)-transformed B cell line and B and T lymphocytes from the same blood donor. Int. J. Radiat. Biol. 2010, 86, 47-55.
80. Bauchinger, M.; Schmid, E.; Braselmann, H. Cell survival and radiation induced chromosome aberrations. II. Experimental findings in human lymphocytes analysed in first and second post-irradiation metaphases. Radiat. Environ. Biophys. 1986, 25, 253-260.
81. Neuvial, P.; Hupe, P.; Brito, I.; Liva, S.; Manie, E.; Brennetot, C.; Radvanyi, F.; Aurias, A.; Barillot, E. Spatial normalization of array-CGH data. BMC Bioinf. 2006, 7, 264.
82. Hupe, P.; Stransky, N.; Thiery, J.P.; Radvanyi, F.; Barillot, E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004, 20, 3413-3422.
83. La Rosa, P.; Viara, E.; Hupe, P.; Pierron, G.; Liva, S.; Neuvial, P.; Brito, I.; Lair, S.; Servant, N.; Robine, N.; Manie, E.; Brennetot, C.; Janoueix-Lerosey, I.; Raynal, V.; Gruel, N.; Rouveirol, C.; Stransky, N.; Stern, M.H.; Delattre, O.; Aurias, A.; Radvanyi, F.; Barillot, E. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006, 22, 2066-2073.
84. Zitzelsberger, H.; Lehmann, L.; Hieber, L.; Weier, H.U.; Janish, C.; Fung, J.; Negele, T.; Spelsberg, F.; Lengfelder, E.; Demidchik, E.P.; Salassidis, K.; Kellerer, A.M.; Werner, M.; Bauchinger, M. Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res. 1999, 59, 135-140.
85. Unger, K.; Zitzelsberger, H.; Salvatore, G.; Santoro, M.; Bogdanova, T.; Braselmann, H.; Kastner, P.; Zurnadzhy, L.; Tronko, N.; Hutzler, P.; Thomas, G. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89, 4272-4279.
86. Perry, P.; Wolff, S. New Giemsa method for the differential staining of sister chromatids. Nature 1974, 251, 156-158.
87. Puck, T.T.; Marcus, P.I.; Cieciura, S.J. Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J. Exp. Med. 1956, 103, 273-283.